Study identifier:D9612R00010
ClinicalTrials.gov identifier:NCT03118778
EudraCT identifier:N/A
CTIS identifier:N/A
Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population: A Descriptive Retrospective Observational Study using Database
Gastrointestinal disease
N/A
No
-
All
90895
Observational
N/A
Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -
Verified 01 Jun 2018 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|